Short-Term Debt to Capital: ICU Medical Inc (ICUI)

Corporate company logo of ICU Medical, Inc. (ICUI)

Risks for ICU Medical, Inc. (ICUI) are linked to potential product quality claims and rising polymer costs, which are pressuring margins. Revenue stability is supported by a global offering of critical care solutions and a broad product line. The current metric is 0.00. The shares shown on this price chart complement the analysis of a mature business producing critical tools for intensive care.

ICUI - ICU Medical Inc Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 10/30/2026

Analytical breakdowns for ICU Medical, Inc.

- stock quotes and analyst forecast:
Stock Price ICU Medical Corp|ICUI - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization ICU Medical Inc|ICUI - Business Value
- book capitalization information:
Book Value per Share ICU Medical|ICUI - Book Valuation of Business|Market Capitalization to Book Value Ratio icumed.com|ICUI - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital ICU Medical, Inc.|ICUI - Long-Term Debt to Capital|Short-Term Debt to Equity ICU Medical|ICUI - Company Debts|Debt to Book Value ICU Medical Inc|ICUI - Company Long-Term Loans and Borrowings|Company Short-Term Debts ICU Medical|Quick Liquidity icumed.com
- earnings and market ratios statistics:
ICUI - Company Profit
General company analysis:ICU Medical Corp ICUI
Brand item of ICU Medical

Assessing the financial stability of ICU Medical, Inc. (ICUI) requires an analysis of the share of short-term liabilities within the equity structure to identify hidden liquidity risks. The trend of short-term debt to equity reflects whether the company is overloading its balance sheet with express loans to fund the robotization of infusion system production, as an increase in this metric signals business degradation and an inevitable share price markdown.

Direct competitors

Short-Term Debt to Capital ISRG|DHR - Current Liabilities to Capital|Short-Term Debt to Capital BDX (Becton Dickinson & Co)|STE: Short-Term Debt to Capital Ratio|West Pharmaceutical Services, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Baxter International Inc. BAX|MASI: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Stevanato Group Corp|TFX (Teleflex Incorporated) - Short-Term Debt to Capital|Short-Term Debt to Capital merit.com|Short-Term Debt to Equity Envista (NVST)|Short-Term Debt to Equity XRAY (Dentsply Sirona Inc)|LeMaitre - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ATRC|STAAR Surgical Company - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient ChromaDex Corp NAGE|ZimVie (ZIMV) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ANGO|Short-Term Debt to Equity Cerus Corp|Teknova Inc (TKNO) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio MGRM (Monogram Technologies)|Short-Term Loans to Capital Ratio STSS|Short-Term Debt to Equity InfuSystem Holdings, Inc. INFU|Ratio of Short-Term Indebtedness to Capital UTMD|KRMD: Short-Term Debt to Equity Ratio|NYXH - Short-Term Debt to Capital|Microbot Medical Inc. (MBOT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio pro-dex.com|ZTEK (Zentek) - Short-Term Debt to Capital|Current Liabilities to Capital Elutia Inc ELUT|Short-Term Debt to Equity Milestone Scientific Corp (MLSS)|NEXGEL Inc - Short-Term Debt to Capital Ratio|Retractable Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio HBIO (Harvard Bioscience Inc.)|FEMY - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient MeihuaMed MHUA|POAI: Short-Term Debt to Capital|CJMB - Short-Term Debt to Capital Coefficient|ATRI (Atrion Corporation) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio neurometrix.com (NURO)